1. Is cognitive dysfunction a complication of adjuvant chemotherapy in the older patient with breast cancer?

   • Arti Hurria
   • Mark Lachs

   Review Paper 12 April 2007 Pages: 259 - 268

2. Dynamic contrast-enhanced MR imaging in screening detected microcalcification lesions of the breast: is there any value?

   • Takayoshi Uematsu
   • Sachiko Yuen
   • Yoshihiro Uchida

   Preclinical Study 25 October 2006 Pages: 269 - 281

   

3. Downregulation of TSLC1 and DAL-1 expression occurs frequently in breast cancer

   • Gerwin Heller
   • Joseph Geradts
   • Sabine Zöchbauer-Müller

   Preclinical Study 27 January 2007 Pages: 283 - 291

   

4. The effects of atamestane and toremifene alone and in combination compared with letrozole on bone, serum lipids and the uterus in an ovariectomized rat model

   • Paul E. Goss
   • Shangle Qi
   • Angela M. Cheung

   Preclinical study 25 October 2006 Pages: 293 - 302

   

5. Altered frontocortical, cerebellar, and basal ganglia activity in adjuvant-treated breast cancer survivors 5–10 years after chemotherapy

   • Daniel H. S. Silverman
   • Christine J. Dy
   • Patricia A. Ganz

   Clinical Trial 29 September 2006 Pages: 303 - 311

   

6. Prediction of response to repeat utilization of anthracycline in recurrent breast cancer patients previously administered anthracycline-containing chemotherapeutic regimens as neoadjuvant or adjuvant chemotherapy

   • Kan Yonemori
   • Noriyuki Katsumata
   • Yasuhiro Fujiwara

   Clinical Trail 25 October 2006 Pages: 313 - 318

   

7. Differentially expressed genes between primary cancer and paired lymph node metastases predict clinical outcome of node-positive breast cancer patients

   • Yumei Feng
   • Baocun Sun
   • Xishan Hao

   Clinical Trial 23 November 2006 Pages: 319 - 329

   

8. Melatonin and estrogen in breast cyst fluids

   • James B. Burch
   • Margie Walling
   • Robert L. Wells

   Epidemiology 24 October 2006 Pages: 331 - 341

   

9. Risk factors for breast carcinoma in situ versus invasive breast cancer in a prospective study of pre- and post-menopausal women

   • Kyndaron S. Reinier
   • Pamela M. Vacek
   • Berta M. Geller

   Epidemiology 25 October 2006 Pages: 343 - 348

10. Prevalence of BRCA1 and BRCA2 mutations in breast cancer patients from Brazil

    • Magda C. B. Gomes
    • Mauricio M. Costa
    • Steven A. Narod

    Epidemiology 25 October 2006 Pages: 349 - 353

11. CDKN2A-positive breast cancers in young women from Poland

    • Tadeusz Dębniak
    • Cezary Cybulski
    • Jan Lubiński

    EPIDEMIOLOGY 24 October 2006 Pages: 355 - 359

12. Diet quality and BRCA-associated breast cancer risk

    • A. Nkondjock
    • P. Ghadirian

    Original paper 25 October 2006 Pages: 361 - 369

13. Does breast cancer associated with CHEK2 1100delC carry characteristics of basal phenotype?

    • Didem S. Dede
    • Ebru Sari
    • Kadri Altundag

    Letter to the Editor 25 October 2006 Pages: 371 - 371

14. Progesterone, progestins, pregnancy and breast cancer risk

    • Gianluigi Ferretti

    Letter to the Editor 25 October 2006 Pages: 373 - 374